Fosamprenavir microbiology: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Fosamprenavir}} {{CMG}}; {{AE}} {AZ}} <ref>{{Cite web | last = | first = | title = LEXIVA (FOSAMPRENAVIR CALCIUM) TABLET, FILM COATED LEXIVA (FOSAMPRENAVIR...")
 
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Fosamprenavir}}
{{Fosamprenavir}}
{{CMG}}; {{AE}} {AZ}}
{{CMG}}; {{AE}} {{AZ}}





Revision as of 14:41, 2 January 2014

Fosamprenavir
LEXIVA® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Overdosage
Clinical Studies
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]



[1]


References

  1. "LEXIVA (FOSAMPRENAVIR CALCIUM) TABLET, FILM COATED LEXIVA (FOSAMPRENAVIR CALCIUM) SUSPENSION [VIIV HEALTHCARE COMPANY]".

Adapted from the FDA Package Insert.